2021 Research Showcase Poster Directory

Poster #Poster FocusPrimary Author's Full Name (First)Primary Author's Full Name (Last)Additional AuthorsTitle of ResearchLocationDateTime
1CancerJessicaMamallapalliJ. Botello; C. XingKava inhibits norepinephrine-induced cAMP production in lung cancer cellsFloor 2, Table 1Monday, April 12, 20218:30am - 10:30am ET
2CancerYumaOrtizJ. Wilkerson; L. McMahonMitragynine reverses paclitaxel chemotherapy-induced peripheral neuropathyFloor 2, Table 2Monday, April 12, 20218:30am - 10:30am ET
3CancerZhishenWangM. Xiong; R. Saksena; L. Cui*Mapping the activities of heparanase with synthetic disaccharidesFloor 2, Table 3Monday, April 12, 20218:30am - 10:30am ET
4CancerRichardMarreroA. Elsayed; N. Nguyen; X. Cao; H. Wu; S. Raimondi; R. Riberio; J. Rubnitz; S. Pounds; J. LambaAssociation of genetic polymorphisms in SAMHD1 gene on clinical outcomes in AMLFloor 2, Table 4Monday, April 12, 20218:30am - 10:30am ET
5CancerZacharyRabinowitzL. CuiDevelopment of bioavailable substrate-based probes for PARP-1Floor 2, Table 5Monday, April 12, 20218:30am - 10:30am ET
6CancerSebastianJuglC. Chang; Y. Wang; J. BrownReal-world patterns of CDK4/6 inhibitor associated interstitial-lung diseaseFloor 2, Table 6Monday, April 12, 20218:30am - 10:30am ET
7CancerJingPeiD. Lyu; Y. Xiao; G. Zheng; D. ZhouExplore the potential of piperlongumine (PL) as a new E3 ligase ligandFloor 2, Table 7Monday, April 12, 20218:30am - 10:30am ET
9CancerKeltonSchleyerJ. Liu; Z. Wang; B. Fetrow; P. Fatland; A. Rollins; V. Wajsbrot; H. Guo; L. CuiExpanding the toolkit of small molecule imaging probes for heparanaseFloor 2, Table 9Monday, April 12, 20218:30am - 10:30am ET
10Pain & AddictionNoorNahidE. Cicali; C. McDonough; Y. Gong; J. JohnsonImpact of CYP2D6 inhibitors on opioid therapy in patients with painFloor 3, Table 1Monday, April 12, 20219:30am - 12:30pm ET
11Pain & AddictionChing-YuanChangJ. Hincapie-Castillo; D. Wilson; W. Lo-CiganicTrends and characteristics of concurrent opioid use with high-risk medicationsFloor 3, Table 2Monday, April 12, 20219:30am - 12:30pm ET
12Pain & AddictionMalloryBurnsS. Intagliata; R. Rogers; S. Kamble; J. Cano; T. Kawesa; B. Avery; L. Toll; C. McCurdySAR and SMR investigation of thiol-Linker containing Sigma Receptor ligandsFloor 3, Table 3Monday, April 12, 20219:30am - 12:30pm ET
13Pain & AddictionJulioZuarth-GonzalezA. Patel; R. Patel; M. Patel; L. Gamez-Jimenez; N. Ho; F. Leon; M. Mottinelli; C. McCurdy; L. McMahon; T. Hiranita.Mitragynine attenuates the development of morphine tolerance and withdrawalFloor 3, Table 4Monday, April 12, 20219:30am - 12:30pm ET
14Pain & AddictionBoSortmanC. Gobin; B. WarrenCocaine seeking is mediated by Fos-expressing ensembles formed during acquisitionFloor 3, Table 5Monday, April 12, 20219:30am - 12:30pm ET
15Pain & AddictionArianaBrice-TuttS. Eans; D. Yakovlev; T. Yakovleva; J. Aldrich; J. McLaughlinDevelopment of a kappa opioid receptor antagonist to treat opioid use disorderFloor 3, Table 6Monday, April 12, 20219:30am - 12:30pm ET
16Pain & AddictionAmyAlleyneL. Wilson; S. Harden; C. McCurdy; C. Frazier; J. McLaughlinSigma-1 ligands modulate methamphetamine sensitization and reward circuitryFloor 3, Table 7Monday, April 12, 20219:30am - 12:30pm ET
17Pain & AddictionErinBertholdS. Kamble; M. Kuntz; S. Kanumuri; T. King; B; Shaikoski; A; Sharma; C. McCurdyComparative pharmockinetic study of cannabidiol formulationsFloor 3, Table 8Monday, April 12, 20219:30am - 12:30pm ET
18Pain & AddictionArianaFigueroaP. Zhang; A. Alleyne; S. Eans; T. Cirino; J. McLaughlin; S. Stevens; B. LiuEffect of peripheral inflammation on microglial phenotypes: impact of SPP1 KOFloor 3, Table 9Monday, April 12, 20219:30am - 12:30pm ET
19Pain & AddictionToddSahagianJ. Thinschmidt; S. Harden; E. Krause; J. Peris, C. FrazierOxytocinergic modulation of VTA --> NAc reward circuitryFloor 3, Table 10Monday, April 12, 20219:30am - 12:30pm ET
20Pain & AddictionMorganCrowleyS. Obeng; V. Pallares; F. Leon; L. Gamez-Jimenez; T. Hiranita; L. McMahon; C. McCurdyPharmacological comparison of a synthetic analog of a mitragyna speciosa alkaloidFloor 3, Table 11Monday, April 12, 20219:30am - 12:30pm ET
21Pain & AddictionYunShenA. Goodin; J. BrownPrescribing measures and medical marijuana physician authorization status in FLFloor 3, Table 12Monday, April 12, 20219:30am - 12:30pm ET
22Chronic DiseasesYahanZhangJ. Bian; J. Huo; S. Yang; Y. Guo; H. ShaoDownstream costs and healthcare utilization of LDCT screening in ADRD patientsFloor 4, Table 1Monday, April 12, 202112:30pm - 3:00pm ET
23Chronic DiseasesPiaopiaoLiR. Patel; S. Vouri; L. Shi; V. Fonseca; H. ShaoThe diminishing cost-effectiveness of newer glucose-lowering drug classes in U.S.Floor 4, Table 2Monday, April 12, 202112:30pm - 3:00pm ET
24Chronic DiseasesZacharyGreenbergM. HeDeep learning directed functionalization of exosomes for precision therapeuticsFloor 4, Table 3Monday, April 12, 202112:30pm - 3:00pm ET
25Chronic DiseasesEarlMorrisN. Tokatly; C. Tortor; S. VouriStatin initiation for secondary prevention of ASCVD events in older adultsFloor 4, Table 4Monday, April 12, 202112:30pm - 3:00pm ET
26Chronic DiseasesShaimaaElbalkinyR. Frye; Y.GongAssociation of CES1 and FXR SNPs with susceptibility to NAFLD and NASH in the UKBFloor 4, Table 5Monday, April 12, 202112:30pm - 3:00pm ET
27Chronic DiseasesGolnooshAlipour-HarisL. Galiano; C. Hernandez; C.A. Leeflang; Z. Shultz; T. Muir; J. BrownMedication regimen complexity and deprescribing in Alzheimer and related dementiaFloor 4, Table 6Monday, April 12, 202112:30pm - 3:00pm ET
28Chronic DiseasesJesusPenaloza AponteS. Eikenberry; J. Smith; A. de Kloet; E. Krause; K. ScottAutomated pipeline for analysis of social behavior and neuronal activity in miceFloor 4, Table 7Monday, April 12, 202112:30pm - 3:00pm ET
29Chronic DiseasesChristelleLteifR. Sharma; J. DuarteMirabegron improves RVSP in a pre-clinical model of PH-HFpEFFloor 4, Table 8Monday, April 12, 202112:30pm - 3:00pm ET
30Chronic DiseasesAimalohiOkpekuA. GoodinImpact of mental health on readmissions among persons living with HIVFloor 4, Table 9Monday, April 12, 202112:30pm - 3:00pm ET
31Chronic DiseasesShuHuangW. Lo-Ciganic; H. ShaoCost-effectiveness of intensive vs. moderate hypertension treatment in US adultsFloor 4, Table 10Monday, April 12, 202112:30pm - 3:00pm ET
32Chronic DiseasesMingxinYangM. Yang; G. de LartigueThe role of nutrient-sensing hippocampal neurons in feedingFloor 4, Table 11Monday, April 12, 202112:30pm - 3:00pm ET
33Chronic DiseasesJordanHowardT. Sahagian; W. Sheng; S. Harden; J. Thinschmidt; C. FrazierCellular neurophysiology of OTR activation in the rat ventral subiculumFloor 4, Table 12Monday, April 12, 202112:30pm - 3:00pm ET
34Infectious DiseasesElhamAminiS. Berger; J. Bulitta; G. HochhausCan pharmacokinetics assess the local bioequivalence of suspension nasal sprays?Floor 5, Table 1Monday, April 12, 20211:30pm - 4:00pm ET
35Infectious DiseasesIkennaUnigweS. Yang; H. Song; W. Lo-Ciganic; R. Cook; H. ParkTrends of STD in the United States ambulatory care clinics from 2005-2016Floor 5, Table 2Monday, April 12, 20211:30pm - 4:00pm ET
36Infectious DiseasesJieqiangZhouY. Lang; T. Kim; X. Tao; A. Sayed; E. Shin; C. Werkman; A. Louie; G. Drusano; C. Landersdorfer; J. BulittaCharacterizing thermal stability of ?-lactam antibiotics in broth, agar and waterFloor 5, Table 3Monday, April 12, 20211:30pm - 4:00pm ET
37Infectious DiseasesDakeLiuT. Wanniarachchi; S. Bruner; Y. DingNovel metabolism of 5-nitroimidazole antibiotics by a pathogen nitroreductaseFloor 5, Table 4Monday, April 12, 20211:30pm - 4:00pm ET
38Infectious DiseasesChaejinKimJ. Barrett; R. Lowenthal; S. Tanimoto; S. Schmidt; V. VozmedianoDevelopment of a physiologically based nasal absorption model and its applicationFloor 5, Table 5Monday, April 12, 20211:30pm - 4:00pm ET
39Infectious DiseasesEvelynFrancoK. Hanrahan; A. BrownFavipiravir inhibits Zika virus in HeLa cells by modulating viral infectivityFloor 5, Table 6Monday, April 12, 20211:30pm - 4:00pm ET
40Infectious DiseasesLobnaElsadekJ. Matthews; S. Nishimura; T. Nakatani; A. Ito; T. Gu; D. Luo; L. Salvador-Reyes; V. Paul; H. Kakeya; H. LueschGenomic and targeted approaches unveil targets of an antifungal natural productFloor 5, Table 7Monday, April 12, 20211:30pm - 4:00pm ET
41Infectious DiseasesEunjeongShinN. Shah; J. Oyer; A. Sayed; D. Sutaria; X. Tao; Y. Lang; J. Zhou; C. Werkman; A. Copik; J. BulittaSynergistic killing of Klebsiella pneumoniae by double ?-lactams combinationsFloor 5, Table 8Monday, April 12, 20211:30pm - 4:00pm ET
42Infectious DiseasesSimonBergerE. Amini; J. Bulitta; G. HochhausAlternative regulatory pathway for generic approval of nasal suspensionsFloor 5, Table 9Monday, April 12, 20211:30pm - 4:00pm ET
43Infectious DiseasesCarolinWerkmanN. Shah; D. Lucas; J. Oyer; M. Megroz; A. Sayed; B. Moya; A. Wright; D. Sutaria; X. Tao; Y. Lang; J. Zhou; E. Shin; R. Jiminez-Nieves; K. Cadet; A. Copik; J. Boyce; J. BulittaSynergistic killing of acinetobacter baumannii via penicillin-binding proteinsFloor 5, Table 10Monday, April 12, 20211:30pm - 4:00pm ET
44Infectious DiseasesGarretRubinY. Zhang; K. Patel; M. Guo; A. Ishee; S. Bruner; Y. DingNew enzymology in the biosynthesis of anti-protease tricyclic peptidesFloor 5, Table 11Monday, April 12, 20211:30pm - 4:00pm ET
45Drug Metabolism, Interactions, & OutcomesDaweiGuanH. ShaoTrends of insulin price across different health insurance plansFloor 6, Table 1Monday, April 12, 20212:30pm - 5:00pm ET
46Drug Metabolism, Interactions, & OutcomesShailinaKeshwaniI. Grande; M. Maguire; A. Goodin; S. Vouri; J. Hincapie-CastilloTrends in utilization of prescription NSAIDs following Florida’s HB21 lawFloor 6, Table 2Monday, April 12, 20212:30pm - 5:00pm ET
47Drug Metabolism, Interactions, & OutcomesRajDesaiS. SmithAccuracy of developing new user cohorts using electronic health records dataFloor 6, Table 3Monday, April 12, 20212:30pm - 5:00pm ET
48Drug Metabolism, Interactions, & OutcomesSeonkyeongYangA. Lipe; M. Boren; J. Hincapie-Castillo; J. Brown; J. Guo; H. Park; C. Chang; D. Wilson; L. Adkins; W. Lo-CiganicTrends in the management of headache in US emergency departments: 2007-2018Floor 6, Table 4Monday, April 12, 20212:30pm - 5:00pm ET
49Drug Metabolism, Interactions, & OutcomesAmirSarayaniJ. Brown; S. Schmidt; A.. WintersteinDoes CYP3A4 induction by topiramate undermine oral contraceptive effectiveness?Floor 6, Table 5Monday, April 12, 20212:30pm - 5:00pm ET
50Drug Metabolism, Interactions, & OutcomesYuliQianJ. MarkowitzPharmacokinetic interactions between methylphenidate and cannabinoidsFloor 6, Table 6Monday, April 12, 20212:30pm - 5:00pm ET
51Drug Metabolism, Interactions, & OutcomesBriannaCostalesR. Matthews; J. Brown; A. GoodinA pharmacovigilance analysis of restless legs syndrome treatments and suicidalityFloor 6, Table 7Monday, April 12, 20212:30pm - 5:00pm ET
52Drug Metabolism, Interactions, & OutcomesBrandonKleeP. Melchert; Y. Qian; C. Galloway; J. MarkowitzInvestigating the pharmacogenomics of ADHD in youth treated with methylphendateFloor 6, Table 8Monday, April 12, 20212:30pm - 5:00pm ET
53Drug Metabolism, Interactions, & OutcomesPhuongTranP. Antonelli; A. WintersteinQuinolone ear drops linked to tendinopathy and tendon ruptureFloor 6, Table 9Monday, April 12, 20212:30pm - 5:00pm ET
54Drug Metabolism, Interactions, & OutcomesNicoleSmolinskiP. Antonelli; A. WintersteinTrends in the diagnosis and treatment of pediatric acute otitis mediaFloor 6, Table 10Monday, April 12, 20212:30pm - 5:00pm ET
55Drug Metabolism, Interactions, & OutcomesBrianCicaliK. Lingineni; R. Cristofoletti; T. Wendl; J. Hoechel; H. Wiesinger; A. Chaturvedula; V. Vozmediano; S. SchmidtLevonorgestrel DDI studies in healthy and obese women using PBPK modelingFloor 6, Table 11Monday, April 12, 20212:30pm - 5:00pm ET
8CancerNamNguyenH. Wu; J. Ping; J. Rubnitz; S. Pounds; J. LambaLeukemic cell proteomic profiling in pediatric AML: a pilot studyFloor 6, Table 12Monday, April 12, 20212:30pm - 5:00pm ET
70PharmD: Group AJuliaLessingJ. Boyle-Taylor; L. Dupree; A. CasapaoCompetent vs. developing abstract skills: does past writing experience matter?Floor 2, Table 1Tuesday, April 13, 20218:00am - 9:30am ET
71PharmD: Group AKyliePaulK. O'Mara; D. de la Cruz; K. KisilewiczComparative outcomes of Intralipid to SMOFlipid in extremely premature neonatesFloor 2, Table 2Tuesday, April 13, 20218:00am - 9:30am ET
72PharmD: Group ASavineHernandezV. Venugopalan; K. DeSear; B. Santevecchi; J. Ashton; K. Cherabuddi; M. Alshaer; C. Peloquin; A. CasapaoOptimizing cefazolin dosing in the treatment of MSSA bacteremiaFloor 2, Table 3Tuesday, April 13, 20218:00am - 9:30am ET
73PharmD: Group AErikKieneggerB. Gonzalez; S. Berger; E. Amini; J. Bulitta; G. HochhausSystematic evaluation of the ex-throat plume properties of MDI formulationsFloor 2, Table 4Tuesday, April 13, 20218:00am - 9:30am ET
74PharmD: Group AAndrewGarciaT. Edminster; I. Molina; M. MuehlbauerImmunomodulator therapy as salvage therapy to failing biologics in IBD patientsFloor 2, Table 5Tuesday, April 13, 20218:00am - 9:30am ET
75PharmD: Group ANazifaKaderyA. Ignacio; A. Tenpas; C. DeRemerEvaluating the use of SGLT-2 inhibitors on weight change and microalbuminuriaFloor 2, Table 6Tuesday, April 13, 20218:00am - 9:30am ET
76PharmD: Group AParminderKaurA. Carr; A. El Ghali; P. Kaur; S. Minor; A. CasapaoEarly real-world evidence of eravacycline in draconian infectionsFloor 2, Table 7Tuesday, April 13, 20218:00am - 9:30am ET
77PharmD: Group AJulieAl-BahouS. Vouri; H. Bhagwandass; I. Valdes; A. AlsuhibaniChanges in overactive bladder medication use before and after bariatric surgeryFloor 2, Table 8Tuesday, April 13, 20218:00am - 9:30am ET
78PharmD: Group ABlakeBartlettM. NorrisLiterature review of potential CYP2D6 inhibitors and their classificationsFloor 2, Table 9Tuesday, April 13, 20218:00am - 9:30am ET
79PharmD: Group AMatthewMuschettJ. BrownRisk factors and costs associated with heart transplant readmissions in the U.S.Floor 2, Table 10Tuesday, April 13, 20218:00am - 9:30am ET
80PharmD: Group AMeganBackusA. Strahorn; S. Matys; A. Yathali; V. GrusauskasAntidepressant prescribing patterns at a student-run free healthcare clinicFloor 2, Table 11Tuesday, April 13, 20218:00am - 9:30am ET
81PharmD: Group AChristenLangleyA. Chizmar; S. Voils; A. CasapaoPerception vs reality: cross-sectional study of the 2020 pharmacy residency matchFloor 2, Table 12Tuesday, April 13, 20218:00am - 9:30am ET
56Post-Doc Trainee/ResidentTengfeiBianY. Wang; J. Botello; Q. Hu; Y. Jiang; A. Zingone; P. Corral; F. Aly; Y. Wu; B. Ryan; L. Jin; C. XingNNAL promotes lung cancer progression in an isomer-dependent mannerFloor 3, Table 1Tuesday, April 13, 20218:30am - 11:30am ET
57Post-Doc Trainee/ResidentXiaoshuPanP. Huang; N. Fernandez; Z. Greenberg; H. Staecker; M. HeCRISPR-Exosome nanoassembles for precise genetic correction in hearing lossFloor 3, Table 2Tuesday, April 13, 20218:30am - 11:30am ET
58Post-Doc Trainee/ResidentDineshThummuriS. Khan; P. Underwood; X. Zhang; P. Zheng; V. Budamagunta; A. Sobh; A. Tagmount; A. Loguinov; E. Williamson; J. Wiegand; R. Hromas; C. Vulpe; G. Zheng; J. Trevino; D. Zhou.BCL-XL PROTAC-Gemcitabine combination as a potent therapy for pancreatic cancerFloor 3, Table 3Tuesday, April 13, 20218:30am - 11:30am ET
59Post-Doc Trainee/ResidentMarwaTantawyM. Chekka; T. Garrett; S. Singh; C. Shah; M. Fradley; R. Cornell; R. Baz; N. Waheed; D. DeRemer; L. Yuan; T. Langaee; K. March; C. Pepine; J. Moreb; Y. GongLactate dehydrogenase B associated with carfilzomib relate cardiotoxicityFloor 3, Table 4Tuesday, April 13, 20218:30am - 11:30am ET
60Post-Doc Trainee/ResidentJuanMoralesJ. Podichetty; J. Burton; N. Hanan; M. Thomas; K. Lingineni; P. Lang; S. David; F. Martin; M. Atkinson; M. Haller; K. Romero; I. O'Doherty; S. Schmidt; S. KimQuantifying heterogeneity contributing to risk of type 1 diabetes diagnosisFloor 3, Table 5Tuesday, April 13, 20218:30am - 11:30am ET
61Post-Doc Trainee/ResidentKhalidElsaafienM. Kirchner; M. Mohammed; S. Eikenberry; C. West; K. Scott; A. de Kloet; J. Stern; E. KrauseAngiotensin signaling in the paraventricular nucelus elevates blood pressureFloor 3, Table 6Tuesday, April 13, 20218:30am - 11:30am ET
62Post-Doc Trainee/ResidentVivekShastriA. Elsayed; L. Chauhan; T. Alonzo; Y. Wang; R. Aplenc; B. Hirsch; A. Gamis; S. Meshinchi; J. LambaDDR-4-SNP score predicts GO response in AML patients: a pathway-directed analysisFloor 3, Table 7Tuesday, April 13, 20218:30am - 11:30am ET
63Post-Doc Trainee/ResidentKimberlyAtkinsonK. Vogel Anderson; M. LoPharmacists increase access to diabetes supplies in an outpatient clinic settingFloor 3, Table 8Tuesday, April 13, 20218:30am - 11:30am ET
64Post-Doc Trainee/ResidentTaoLongR.Cristofoletti; V. Michaud; P. Dow; J. Turgeon; S. SchmidtPBPK modeling to assess CYP2D6-mediated DDI on tramadol and metabolite exposuresFloor 3, Table 9Tuesday, April 13, 20218:30am - 11:30am ET
65Post-Doc Trainee/ResidentMichellePresslyS. SchmidtAgent-based approach to understanding bone remodeling in osteoporosisFloor 3, Table 10Tuesday, April 13, 20218:30am - 11:30am ET
66Post-Doc Trainee/ResidentLauraHanoldA. Cheek; J. AldrichThe peptide [D-Trp]CJ-15,208 regulates proteins in the c-Myc degradation pathwayFloor 3, Table 11Tuesday, April 13, 20218:30am - 11:30am ET
67Post-Doc Trainee/ResidentYuzhiWangT. Bian; L. Jin; C. XingNicotine exposure induces resistance to chemotherapy in small cell lung cancerFloor 3, Table 12Tuesday, April 13, 20218:30am - 11:30am ET
68Post-Doc Trainee/ResidentYinzhiLangJ. Zhou; N. Smith; X. Tao; A. Sayed; E. Shin; W. Carolin; R. Cha; B. Tsuji; J. BulittaOuter membrane (OM) permeability of six ?-lactams in New Delhi metallo-?-lactamasFloor 3, Table 13Tuesday, April 13, 20218:30am - 11:30am ET
69Post-Doc Trainee/ResidentHamedKianmehrJ. Guo; J. Luo; L. Shi; V. Fonseca; H. ShaoTo examine patient characteristics on incident congestive heart failure (CHF)Floor 3, Table 14Tuesday, April 13, 20218:30am - 11:30am ET
82PharmD: Group BJisooKimN. Seligson; B. Duong; K. Blake; K. CookPharmacogenomic medication use in pediatrics patients with sickle cell diseaseFloor 4, Table 1Tuesday, April 13, 20219:00am - 10:30am ET
83PharmD: Group BShivaniMehtaS. Mehta; E. Elwood; K. Vigal; G. Rosier; R. Rhoden; A. Williams; A. Cobb; P. Williams; F. Kaba; J. Alonso; E. Eddy; R. Copper-DeHoffGenetic testing to understand and address renal disease disparities across the USFloor 4, Table 2Tuesday, April 13, 20219:00am - 10:30am ET
84PharmD: Group BNatashaEmanuelT. Larkin; A. Elsayed; R. Rafiee; B. Greer; B. Horn; J. LambaIdentification of SNPs to optimize the treatment of acute childhood leukemiaFloor 4, Table 3Tuesday, April 13, 20219:00am - 10:30am ET
85PharmD: Group BMahnoorIzharP. Molina; M. Thomas; E. Quesinberry; N. SeligsonSecondary genomic variants across fusion-driven sarcomasFloor 4, Table 4Tuesday, April 13, 20219:00am - 10:30am ET
86PharmD: Group BMonicaBennettS. Millis; D. Jin; N. Grosenbacher; C. Stets; J. Elvin; W. Miles; J. Hays; J. Chen; N. SeligsonIdentifying predictors of loss of heterozygosity in leiomyosarcomaFloor 4, Table 5Tuesday, April 13, 20219:00am - 10:30am ET
87PharmD: Group BWendyCaba PilotoE. Mougey; C. Gutiérrez-Junquera; S. Fernández-Fernández; M. Luz Cilleruelo; A. Rayo; B. Borrell; E. Román; C. González-Lois; M. Chao; H. Al-Atrash; J. FranciosiTSLP/WDR36 variant associates with PPIREEFloor 4, Table 6Tuesday, April 13, 20219:00am - 10:30am ET
88PharmD: Group BErinShepardY. Coll; S. Millis; J. Hays; J. Chen; N. SeligsonAlterations in histone H3 modifying henes in synovial sarcomaFloor 4, Table 7Tuesday, April 13, 20219:00am - 10:30am ET
89PharmD: Group BCharlesVerduzcoC. Lawrence; A. Phillips; T. Tran; D. WangRegulatory polymorphisms in CYP2D6 and their clinical implicationsFloor 4, Table 8Tuesday, April 13, 20219:00am - 10:30am ET
90PharmD: Group BBreonnaHarrisonR. Callender; J. Lamba; C. RamosImpact of gene associated methotrexate toxicity in acute lymphoblastic leukemiaFloor 4, Table 9Tuesday, April 13, 20219:00am - 10:30am ET
91PharmD: Group BBradleyHallN. Desai; A. Elchynski; Y. Marks; D. D'Silva; K. NguyenUtilizing a HCI approach to evaluate the design of current PGx-CDSFloor 4, Table 10Tuesday, April 13, 20219:00am - 10:30am ET
92PharmD: Group BConnieMeiZ. Gruen; L. Dumeny; L. CavallariPharmacogenomics implementation in the arthroplasty settingFloor 4, Table 11Tuesday, April 13, 20219:00am - 10:30am ET
93PharmD: Group BOrnielCabanE. Alini; R. Glaubrecht; A. Parchment; N. SeligsonPrevalence of single cell transcriptomic heterogeneity in sarcomaFloor 4, Table 12Tuesday, April 13, 20219:00am - 10:30am ET
94PharmD: Group BDaniellePellettL. Garayeva; P. Martinez-Quinones; J. Ngo; H. Fellows; J. DuarteClinical implementation of preemptive pharmacogenetic testing in the literatureFloor 4, Table 13Tuesday, April 13, 20219:00am - 10:30am ET
95PharmD: Group BHanhTranL. Becirevic; N. Emanuel; M. Lofy; V. Shastri; J. LambaAra-C SNP score to personalize cytarabine dosing: a retrospective studyFloor 4, Table 14Tuesday, April 13, 20219:00am - 10:30am ET
96PharmD: Group BMelissaCuevasJ. Kelly; J. LambaGene associated asparaginase hypersensitivity in pediatric ALLFloor 4, Table 15Tuesday, April 13, 20219:00am - 10:30am ET
110Undergraduate StudentShelbyLuckeyA. Singh; G. de LartigueBardet-Biedl syndrome 5 gene mutation promotes leptin resistance and obesityFloor 5, Table 1Tuesday, April 13, 202110:00 - 11:30am ET
111Undergraduate StudentIsadoraBragaA. Araujo; G. De LartigueAsymmetrical recruitment of vagal motor neurons by vagal sensory neuronsFloor 5, Table 2Tuesday, April 13, 202110:00 - 11:30am ET
112Undergraduate StudentKatelynRourkA. Singh; A. Bernier; G. de LartigueCan sweetened drinks impair metformin’s effect on glucose control in obese mice?Floor 5, Table 3Tuesday, April 13, 202110:00 - 11:30am ET
113Undergraduate StudentAlbertoJimenez YbargollinG. Zeng; W. Zhao; Z. Chen; X. Li; F. Liang; L. CuiEpigenetic control of heparanase expression through CRISPR/dCas9Floor 5, Table 4Tuesday, April 13, 202110:00 - 11:30am ET
114Undergraduate StudentVictoriaPallaresS. Obeng; M. Mottinelli; C. McCurdy; L. McMahon; T. HiranitaIn vitro pharmacological characterization of novel fentanyl analogsFloor 5, Table 5Tuesday, April 13, 202110:00 - 11:30am ET
115Undergraduate StudentGabrielLemeI. Braga; A. de Araujo; G. de LartigueDifferential control of food intake by left and right vagal sensory neuronsFloor 5, Table 6Tuesday, April 13, 202110:00 - 11:30am ET
116Undergraduate StudentJaneHufnagelS. Obeng; F. Leon; L. Restrepo; L. Gamez-Jimenez; A. Patel; N. Ho; T. Braun; J. Fortner; M. Crowley; V. Pallares; M. Mottinelli; C. Lopera-Londono; C. McCurdy; L. McMahon; T. HiranitaComparison of mu-opioid receptor activity of Kratom alkaloid and its metaboliteFloor 5, Table 7Tuesday, April 13, 202110:00 - 11:30am ET
97PharmD: Group CMoniqueHookB. Dragoljevic; E. McKenna; A. Nguyen; D. Valentin; K. Nguyen; K. Wiisanen; L. Cavallari; A. Elchynski; E. CicaliEvaluation of prescriber responses to TPMT pre-test alerts at UF HealthFloor 6, Table 1Tuesday, April 13, 202110:00 - 11:30am ET
98PharmD: Group CJoshuaBilbreyY. Ortiz; J. Felix; L. McMahon; J. WilkersonEvaluating effects of terpenoid compounds in mice with chronic neuropathic painFloor 6, Table 2Tuesday, April 13, 202110:00 - 11:30am ET
99PharmD: Group CTaylorEaseyJ. Hincapie-Castillo; S. Vouri; A. GoodinImpact of opioid acute pain limitation laws on opioid overdose deathsFloor 6, Table 3Tuesday, April 13, 202110:00 - 11:30am ET
100PharmD: Group CLismauryGalianoC. Hernandez Zengotita; J. Brown; G. Alipour HarisReview of medication regimen for patients with ADRD in sleep apnea guidelines.Floor 6, Table 4Tuesday, April 13, 202110:00 - 11:30am ET
101PharmD: Group CMaryamDeraviT. Tablante; L. Adkins; A. Goodin; J. Hincapie-CastilloSystematic review of social media data sources for substance use trendsFloor 6, Table 5Tuesday, April 13, 202110:00 - 11:30am ET
102PharmD: Group CSophieBennettE. Altamura; S. Bell; K. Cabrera; B. Zhang; C. Kim; V. VozmedianoReview of nasal route for systemic and brain delivery: advantages and challengesFloor 6, Table 6Tuesday, April 13, 202110:00 - 11:30am ET
103PharmD: Group CNatalieOurhaanH. Bhagwandass; A. Goodin; J. Hincapie-CastilloUtilization trends of amphetamine-containing medications following law changesFloor 6, Table 7Tuesday, April 13, 202110:00 - 11:30am ET
104PharmD: Group CIvannaGrandeS. Keshwani; J. Hincapie-CastilloImpact of opioid prescribing limits on NSAID use in state Medicaid programsFloor 6, Table 8Tuesday, April 13, 202110:00 - 11:30am ET
105PharmD: Group CIndiaAucheyJ. BrownCannabis use in pregnancy: a review of the literatureFloor 6, Table 9Tuesday, April 13, 202110:00 - 11:30am ET
106PharmD: Group CAviPatelS. Obeng; L Restrepo; L. Gamez-Jimenez; N. Ho; F. León; M. Mottinelli; C. McCurdy; L. McMahon; T. HiranitaThe primary kratom alkaloid mitragynine as an in vivo adrenergic-alpha2 receptorFloor 6, Table 10Tuesday, April 13, 202110:00 - 11:30am ET
107PharmD: Group CTychellBranchcombY. Shen; H. Bhagwandass; S. Galvez; I. Grande; J. Lessing; M. Mollanazar; N. Ourhaan; R. Oueini; M. Sasser; I. Valdes; A. Jadubans; J. Hollmann; M. Maguire; S. Usmani; S. Vouri; J. Hincapie-Castillo; L. Adkins; A. GoodinChronic opioid therapy: a scoping literature reviewFloor 6, Table 11Tuesday, April 13, 202110:00 - 11:30am ET
108PharmD: Group CJoyceHernandez MaldonadoO. GrundmannNon-HIV DDI's of artemisinin-based combination therapies in malaria treatmentFloor 6, Table 12Tuesday, April 13, 202110:00 - 11:30am ET
109PharmD: Group CCarolineLeeflangJ. Brown; G. Alipour Haris; C. Hernandez ZengotitaPsychiatric medication regimen complexity and eprescribing in ADRDFloor 6, Table 13Tuesday, April 13, 202110:00 - 11:30am ET